Assetmark Inc. Raises Stock Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Assetmark Inc. raised its position in Addus HomeCare Co. (NASDAQ:ADUS) by 11.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,169 shares of the company’s stock after buying an additional 121 shares during the quarter. Assetmark Inc.’s holdings in Addus HomeCare were worth $156,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Texas Permanent School Fund Corp lifted its stake in Addus HomeCare by 0.6% in the second quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock valued at $1,636,000 after buying an additional 82 shares during the last quarter. Arizona State Retirement System lifted its stake in Addus HomeCare by 2.0% in the second quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock valued at $527,000 after buying an additional 87 shares during the last quarter. UMB Bank n.a. lifted its stake in Addus HomeCare by 64.2% in the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after buying an additional 88 shares during the last quarter. Inspire Investing LLC raised its stake in shares of Addus HomeCare by 3.3% during the third quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock worth $414,000 after purchasing an additional 100 shares during the last quarter. Finally, New York State Teachers Retirement System raised its stake in shares of Addus HomeCare by 1.2% during the third quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock worth $1,132,000 after purchasing an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Performance

NASDAQ:ADUS opened at $119.78 on Monday. The stock has a fifty day moving average price of $128.99 and a two-hundred day moving average price of $122.59. The stock has a market capitalization of $2.17 billion, a price-to-earnings ratio of 27.41, a PEG ratio of 2.09 and a beta of 1.04. Addus HomeCare Co. has a 1 year low of $85.43 and a 1 year high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02. The company had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.03 earnings per share. On average, analysts predict that Addus HomeCare Co. will post 4.58 EPS for the current year.

Wall Street Analyst Weigh In

ADUS has been the subject of several analyst reports. Macquarie restated an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research note on Monday, November 4th. Royal Bank of Canada restated an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a research note on Thursday. Stephens upped their price target on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. TD Cowen upped their price target on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. Finally, Oppenheimer upped their price target on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. One research analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $131.63.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. This represents a 75.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Esteban Lopez sold 500 shares of the stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the sale, the director now directly owns 3,366 shares in the company, valued at approximately $429,165. The trade was a 12.93 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 22,917 shares of company stock valued at $3,050,082. Insiders own 4.60% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.